Noemi Marco Guzman

Noemi Marco Guzman

Auto-generated profile, based on publicly available information

Noemi Marco Guzman

Dpto. Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2013 in RNA Biology
Verified
Journal Article
Open access
CDCésar Díez-Villaseñor
César Díez-Villaseñor
NGNoemí M. Guzmán
Noemí M. Guzmán
CACristóbal Almendros
Cristóbal Almendros
JGJesús García-Martínez
Jesús García-Martínez
FMFrancisco J. M. Mojica
Francisco J. M. Mojica
Prokaryotes immunize themselves against transmissible genetic elements by the integration (acquisition) in clustered regularly interspaced short palindromic repeats (CRISPR) loci of spacers homolog...

2 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EGEnriqueta Garcia-Gutierrez
Enriqueta Garcia-Gutierrez
CACristóbal Almendros
Cristóbal Almendros
FMFrancisco J. M. Mojica
Francisco J. M. Mojica
NGNoemí M. Guzmán
Noemí M. Guzmán
JGJesús García-Martínez
Jesús García-Martínez
Guide RNA molecules (crRNA) produced from clustered regularly interspaced short palindromic repeat (CRISPR) arrays, altogether with effector proteins (Cas) encoded by cognate cas (CRISPR associated) genes, mount an interference mechanism (CRISPR-Cas) that limits acquisition of foreign DNA in Bacteria and Archaea. The specificity of this action is provided by the repeat intervening spacer carried in the crRNA, which upon hybridization with complementary sequences enables their degradation by a Cas endonuclease. Moreover, CRISPR arrays are dynamic landscapes that may gain new spacers from infecting elements or lose them for example during genome replication. Thus, the spacer content of a strain determines the diversity of sequences that can be targeted by the corresponding CRISPR-Cas system reflecting its functionality. Most Escherichia coli strains possess either type I-E or I-F CRISPR-Cas systems. To evaluate their impact on the pathogenicity of the species, we inferred the pathotype and pathogenic potential of 126 strains of this and other closely related species and analyzed their repeat content. Our results revealed a negative correlation between the number of I-E CRISPR units in this system and the presence of pathogenicity traits: the median number of repeats was 2.5-fold higher for commensal isolates (with 29.5 units, range 0–53) than for pathogenic ones (12.0, range 0–42). Moreover, the higher the number of virulence factors within a strain, the lower the repeat content. Additionally, pathogenic strains of distinct ecological niches (i.e., intestinal or extraintestinal) differ in repeat counts. Altogether, these findings support an evolutionary connection between CRISPR and pathogenicity in E. coli.

28 February 2014 in mBio
Verified
Journal Article
Open access
PDF file
CACristóbal Almendros
Cristóbal Almendros
FMFrancisco J. M. Mojica
Francisco J. M. Mojica
CDCésar Díez-Villaseñor
César Díez-Villaseñor
NGNoemí M Guzmán
Noemí M Guzmán
JGJesús García-Martínez
Jesús García-Martínez
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated ( cas ) genes constitute the CRISPR-Cas systems found in the Bacteria and Archaea domains. At least in some strains they provide an efficient barrier against transmissible genetic elements such as plasmids and viruses. Two CRISPR-Cas systems have been identified in Escherichia coli , pertaining to subtypes I-E ( cas -E genes) and I-F ( cas -F genes), respectively. In order to unveil the evolutionary dynamics of such systems, we analyzed the sequence variations in the CRISPR-Cas loci of a collection of 131 E. coli strains. Our results show that the strain grouping inferred from these CRISPR data slightly differs from the phylogeny of the species, suggesting the occurrence of recombinational events between CRISPR arrays. Moreover, we determined that the primary cas -E genes of E. coli were altogether replaced with a substantially different variant in a minor group of strains that include K-12. Insertion elements play an important role in this variability. This result underlines the interchange capacity of CRISPR-Cas constituents and hints that at least some functional aspects documented for the K-12 system may not apply to the vast majority of E. coli strains. IMPORTANCE Escherichia coli is a model microorganism for the study of diverse aspects such as microbial evolution and is a component of the human gut flora that may have a direct impact in everyday life. This work was undertaken with the purpose of elucidating the evolutionary pathways that have led to the present situation of its significantly different CRISPR-Cas subtypes (I-E and I-F) in several strains of E. coli . In doing so, this information offers a novel and wider understanding of the variety and relevance of these regions within the species. Therefore, this knowledge may provide clues helping researchers better understand these systems for typing purposes and make predictions of their behavior in strains that, depending on their particular genetic dotation, would result in different levels of immunity to foreign genetic elements.

26 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CACristóbal Almendros
Cristóbal Almendros
NGNoemí M. Guzmán
Noemí M. Guzmán
CDCésar Díez-Villaseñor
César Díez-Villaseñor
JGJesús García-Martínez
Jesús García-Martínez
FMFrancisco J. M. Mojica
Francisco J. M. Mojica
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR associated (cas) genes conform the CRISPR-Cas systems of various bacteria and archaea and produce degradation of invading nucleic acids containing sequences (protospacers) that are complementary to repeat intervening spacers. It has been demonstrated that the base sequence identity of a protospacer with the cognate spacer and the presence of a protospacer adjacent motif (PAM) influence CRISPR-mediated interference efficiency. By using an original transformation assay with plasmids targeted by a resident spacer here we show that natural CRISPR-mediated immunity against invading DNA occurs in wild type Escherichia coli. Unexpectedly, the strongest activity is observed with protospacer adjoining nucleotides (interference motifs) that differ from the PAM both in sequence and location. Hence, our results document for the first time native CRISPR activity in E. coli and demonstrate that positions next to the PAM in invading DNA influence their recognition and degradation by these prokaryotic immune systems.

18 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AGAntonio Galiana
Antonio Galiana
JCJavier Coy
Javier Coy
AGAdelina Gimeno
Adelina Gimeno
NGNoemi Marco Guzman
Noemi Marco Guzman
FRFrancisco Rosales
Francisco Rosales
JRJuan Carlos Rodríguez
Juan Carlos Rodríguez
Blood infections are serious complex conditions that generally require rapid diagnosis and treatment. The big challenge is to reduce the time necessary to make a diagnosis with current clinical microbiological methods so as to improve the treatment given to patients. In this study, we assess for the first time the Sepsis Flow Chip assay, which is a novel diagnostic assay for simultaneous rapid-detection of the vast majority of bloodstream pathogens, including Gram-positive and Gram-negative bacteria and fungi, in the same assay, and for the detection of most common antibiotic resistance genes. The SFC assay is based on multiplex PCR and low density DNA arrays. Positive blood cultures from 202 consecutive bacteremia patients were analyzed by SFC assay and the results were compared with the results obtained by the gold standard methodology used in clinical microbiology diagnostic laboratories (EUCAST guidelines). SFC assay overall sensitivity and specificity for bacterial identification were 93.3% and 100% respectively and sensitivity and specificity for the identification of antibiotic genetic resistance determinants were 93.6% and 100% respectively. This is the first evaluation of SFC assay in clinical samples. This new method appears to be very promising by combining the high number of distinct pathogens and genetic resistance determinants identified in a single assay. Further investigations should be done to evaluate the usefulness of this assay in combination with clinical multidisciplinary groups (stewardship), in order for the results to be applied appropriately to the management of patients`infectious processes.

4 June 2018 in Microbial Cell
Verified
Journal Article
Open access
JGJesús García-Martínez
Jesús García-Martínez
RMRafael D. Maldonado
Rafael D. Maldonado
NGNoemí M. Guzmán
Noemí M. Guzmán
FMFrancisco J. M. Mojica
Francisco J. M. Mojica
The CRISPR conundrum: evolve and maybe die, or survive and risk stagnation –